We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+13.38%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
-$106M
(-9.2%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-16.63%
Top 10 Holdings %
Top 10 Hldgs %
5.73%
Holding
1,387
New
364
Increased
246
Reduced
349
Closed
422
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$5.05M |
| 2 |
Century Aluminum
CENX
|
+$4.6M |
| 3 |
CBM
Cambrex Corporation
CBM
|
+$4.54M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$4.51M |
| 5 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OneSpan
OSPN
|
+$7.67M |
| 2 |
Lattice Semiconductor
LSCC
|
+$7.09M |
| 3 |
Mercury Insurance
MCY
|
+$5.38M |
| 4 |
Omnicell
OMCL
|
+$5.15M |
| 5 |
Maximus
MMS
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.11% |
| 2 | Technology | 14.11% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 10.88% |
| 5 | Financials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CQB
151
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
| $1.91M | 0.18% |
131,824
-30,102
| -19% | -$429K |
|
152
Alamo Group
ALG
$2.01B
| $1.9M | 0.18% |
39,250
+15,091
| +62% | +$675K |
|
|
IL
153
DELISTED
IntraLinks Holdings Inc.
IL
| $1.89M | 0.18% |
159,183
-22,063
| -12% | -$214K |
|
|
IPHS
154
DELISTED
Innophos Holdings, Inc.
IPHS
| $1.89M | 0.18% |
32,344
-40,055
| -55% | -$2.25M |
|
155
AngioDynamics
ANGO
$562M
| $1.89M | 0.18% |
99,214
+8,138
| +9% | +$138K |
|
|
CBL
156
DELISTED
CBL& Associates Properties, Inc.
CBL
| $1.88M | 0.18% |
96,846
+7,761
| +9% | +$146K |
|
|
CMD
157
DELISTED
Cantel Medical Corporation
CMD
| $1.88M | 0.18% |
43,408
+24,400
| +128% | +$997K |
|
158
Argan
AGX
$7.98B
| $1.87M | 0.18% |
55,505
+52
| +0.1% | +$1.7K |
|
|
EGL
159
DELISTED
Engility Holdings, Inc.
EGL
| $1.86M | 0.18% |
43,498
+4,570
| +12% | +$182K |
|
|
EE
160
DELISTED
El Paso Electric Company
EE
| $1.85M | 0.18% |
+46,296
| New | +$1.75M |
|
|
GTIV
161
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $1.85M | 0.18% |
97,110
-69,539
| -42% | -$1.33M |
|
|
162
OneSpan
OSPN
$562M
| $1.84M | 0.18% |
65,189
-309,786
| -83% | -$7.67M |
|
163
REX American Resources
REX
$1.46B
| $1.84M | 0.18% |
+177,984
| New | +$1.97M |
|
|
IXYS
164
DELISTED
IXYS Corp
IXYS
| $1.81M | 0.17% |
143,414
-288,724
| -67% | -$3.25M |
|
165
CorVel
CRVL
$3.05B
| $1.8M | 0.17% |
145,245
-52,413
| -27% | -$603K |
|
166
Progress Software
PRGS
$1.55B
| $1.8M | 0.17% |
+66,648
| New | +$1.73M |
|
167
ArcBest
ARCB
$3.44B
| $1.8M | 0.17% |
38,726
-73,773
| -66% | -$2.99M |
|
|
XOXO
168
DELISTED
Xo Group Inc
XOXO
| $1.79M | 0.17% |
+98,219
| New | +$1.39M |
|
169
Titan International
TWI
$516M
| $1.78M | 0.17% |
+167,929
| New | +$1.73M |
|
170
Oppenheimer Holdings
OPY
$1.17B
| $1.77M | 0.17% |
76,214
+39,364
| +107% | +$899K |
|
|
ANK
171
DELISTED
ATLANTIC TELE-NETWORK,INC
ANK
| $1.74M | 0.17% |
25,750
-2,518
| -9% | -$170K |
|
|
FOE
172
DELISTED
Ferro Corporation
FOE
| $1.74M | 0.17% |
133,875
+451
| +0.3% | +$5.92K |
|
173
Daktronics
DAKT
$941M
| $1.73M | 0.16% |
137,882
-157,958
| -53% | -$1.99M |
|
|
RLD
174
DELISTED
REALD INC COM STK
RLD
| $1.72M | 0.16% |
+145,382
| New | +$1.64M |
|
|
KNL
175
DELISTED
Knoll, Inc.
KNL
| $1.71M | 0.16% |
80,760
+45,101
| +126% | +$861K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2014 Portfolio in Review
As of Q4 2014, TFS Capital held 1,387 positions worth $1.05B, down 9.2% from $1.15B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
TFS Capital withdrew a net $174M in Q4 2014, closing 422 positions and reducing 349 holdings. Its most notable exit was Lattice Semiconductor, an estimated $7.09M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, TFS Capital opened a new position in Infinity Pharmaceuticals, Inc. worth $5.86M.
- TFS Capital's largest Q4 2014 buy was Infinity Pharmaceuticals, Inc.: 347,088 shares worth $5.86M.
- TFS Capital added most to Cambrex Corporation in Q4 2014, an estimated $4.54M increase.
- TFS Capital's biggest Q4 2014 reduction was OneSpan, cutting an estimated $7.67M.
- TFS Capital fully exited Lattice Semiconductor in Q4 2014, selling an estimated $7.09M.
- TFS Capital's ten largest holdings make up 5.7% of its $1.05B portfolio in Q4 2014.
- TFS Capital opened 364 new positions and closed 422 in Q4 2014.
- TFS Capital's portfolio value fell 9.2% quarter-over-quarter to $1.05B.
Based on TFS Capital's 13F filing for Q4 2014, filed 29 Jan 2015.